BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 716892)

  • 41. Expression of a homeobox gene (SIX5) in borderline ovarian tumours.
    Winchester C; Robertson S; MacLeod T; Johnson K; Thomas M
    J Clin Pathol; 2000 Mar; 53(3):212-7. PubMed ID: 10823141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian tumors: the ultrastructure of benign serous cystadenomas.
    Roberts DK; Wharton JT; Marshall RB; Horbelt DV
    J Kans Med Soc; 1975 Jun; 76(6):132-4, 12A. PubMed ID: 1133499
    [No Abstract]   [Full Text] [Related]  

  • 43. Ovarian Epithelial Inclusions With Mucinous Differentiation: A Clinicopathologic Study of 42 Cases.
    Seidman JD; Krishnan J
    Int J Gynecol Pathol; 2017 Jul; 36(4):372-376. PubMed ID: 27801756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses.
    Lu D; Davila RM; Pinto KR; Lu DW
    Diagn Cytopathol; 2004 May; 30(5):320-4. PubMed ID: 15108229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serous and seromucinous infantile ovarian cystadenomas--a study of 42 cases.
    Massicot R; Rousseau V; Darwish AA; Sauvat F; Jaubert F; Nihoul-Fékété C
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):64-7. PubMed ID: 18996636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
    Rutgers JL; Scully RE
    Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
    Tashiro Y; Yonezawa S; Kim YS; Sato E
    Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
    Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
    J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrastructural studies on the morphogenesis of psammoma bodies in ovarian serous neoplasia.
    Ferenczy A; Talens M; Zoghby M; Hussain SS
    Cancer; 1977 Jun; 39(6):2451-9. PubMed ID: 872045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
    Raju U; Fine G; Greenawald KA; Ohorodnik JM
    Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intestine-associated antigens in ovarian tumours: an immunohistological study.
    De Boer WG; Ma J; Nayman J
    Pathology; 1981 Jul; 13(3):547-55. PubMed ID: 7029434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serous borderline ovarian tumors].
    Zipprich K; Albrecht G; Canzler E
    Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunolocalization of alpha-amylase in ovarian mucinous tumours.
    Griffin NR; Wells M
    Int J Gynecol Pathol; 1990; 9(1):41-6. PubMed ID: 2294062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
    Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
    Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cell line, ROSE 199, derived from normal rat ovarian surface epithelium.
    Adams AT; Auersperg N
    Exp Cell Biol; 1985; 53(4):181-8. PubMed ID: 4029476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
    Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.
    Behrens P; Rothe M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2001 Aug; 8(2):149-54. PubMed ID: 11445865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.